COMy 2019 | Enhancing immune response in multiple myeloma

Sagar Lonial

Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA, discusses novel targets for enhanced immune response in multiple myeloma, including proteasome, BCL-2 and MCL-1 inhibitors. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video